I Großimlinghaus1, P Falkai2, W Gaebel3, A Hasan2, M Jänner4, B Janssen4, D Reich-Erkelenz5, L Grüber2, V Böttcher2, T Wobrock6,7, J Zielasek1. 1. Klinik und Poliklinik für Psychiatrie und Psychotherapie, LVR-Institut für Versorgungsforschung, WHO Collaborating Center for Quality Assurance and Empowerment in Mental Health, Medizinische Fakultät, LVR-Klinikum Düsseldorf, Heinrich-Heine-Universität, Bergische Landstr. 2, 40629, Düsseldorf, Deutschland. 2. Klinik für Psychiatrie und Psychotherapie, Ludwig-Maximilians-Universität, München, Deutschland. 3. Klinik und Poliklinik für Psychiatrie und Psychotherapie, LVR-Institut für Versorgungsforschung, WHO Collaborating Center for Quality Assurance and Empowerment in Mental Health, Medizinische Fakultät, LVR-Klinikum Düsseldorf, Heinrich-Heine-Universität, Bergische Landstr. 2, 40629, Düsseldorf, Deutschland. Wolfgang.Gaebel@lvr.de. 4. Klinik und Poliklinik für Psychiatrie und Psychotherapie, Medizinische Fakultät, LVR-Klinikum Düsseldorf, Heinrich-Heine-Universität, Düsseldorf, Deutschland. 5. Institut für Psychiatrische Phänomik und Genomik, Ludwig-Maximilians-Universität München, München, Deutschland. 6. Zentrum für Seelische Gesundheit, Kreiskliniken Darmstadt-Dieburg, Groß-Umstadt, Deutschland. 7. Klinik für Psychiatrie und Psychotherapie, Universitätsmedizin Göttingen, Göttingen, Deutschland.
Abstract
BACKGROUND: Prior to nationwide implementation, the feasibility of newly developed quality indicators must be assessed. The aim of this multicenter feasibility test was an evaluation of the measurability of cross-sectoral quality indicators for depression and schizophrenia by means of routine data. METHODS: The feasibility of the quality indicators was assessed in ten specialist clinics for psychiatry and psychotherapy by means of retrospective analyses of anonymous routine data. The data were extracted from the routine clinical documentation of the hospital information systems and the data from the admission and discharge sheets of the basic documentation in psychiatry (BADO) were additionally used for some clinics. Analyses were conducted for all cases of adults diagnosed with depression or schizophrenia within predefined assessment periods. RESULTS: In total five indicators for depression and nine indicators for schizophrenia were assessed and evaluated as measurable or measurable to a limited extent, sometimes with slight adaptations in the operationalization of the indicator. Due to variations in documentation, some indicators could not be calculated for all clinics. Most indicators could be collated with the data from the BADO. CONCLUSION: An assessment of indicators that measure quality-relevant aspects of care in depression and schizophrenia, is partially feasible by means of current routine data documentation analysis from the participating clinics. However, differing documentation methodologies in the participating clinics impeded a uniform assessment; therefore, for the implementation of nationwide minimum standards for the quality assurance of mental healthcare, a uniform cross-sectoral documentation methodology should be adapted to consensus and relevant quality indicators. The BADO appears to be a suitable instrument for this purpose.
BACKGROUND: Prior to nationwide implementation, the feasibility of newly developed quality indicators must be assessed. The aim of this multicenter feasibility test was an evaluation of the measurability of cross-sectoral quality indicators for depression and schizophrenia by means of routine data. METHODS: The feasibility of the quality indicators was assessed in ten specialist clinics for psychiatry and psychotherapy by means of retrospective analyses of anonymous routine data. The data were extracted from the routine clinical documentation of the hospital information systems and the data from the admission and discharge sheets of the basic documentation in psychiatry (BADO) were additionally used for some clinics. Analyses were conducted for all cases of adults diagnosed with depression or schizophrenia within predefined assessment periods. RESULTS: In total five indicators for depression and nine indicators for schizophrenia were assessed and evaluated as measurable or measurable to a limited extent, sometimes with slight adaptations in the operationalization of the indicator. Due to variations in documentation, some indicators could not be calculated for all clinics. Most indicators could be collated with the data from the BADO. CONCLUSION: An assessment of indicators that measure quality-relevant aspects of care in depression and schizophrenia, is partially feasible by means of current routine data documentation analysis from the participating clinics. However, differing documentation methodologies in the participating clinics impeded a uniform assessment; therefore, for the implementation of nationwide minimum standards for the quality assurance of mental healthcare, a uniform cross-sectoral documentation methodology should be adapted to consensus and relevant quality indicators. The BADO appears to be a suitable instrument for this purpose.
Authors: R D Stieglitz; M Wolfersdorf; R Metzger; A Ruppe; S Stabenow; C Hornstein; F Keller; G Schell; M Berger Journal: Nervenarzt Date: 1998-01 Impact factor: 1.214
Authors: I Großimlinghaus; P Falkai; W Gaebel; B Janssen; D Reich-Erkelenz; T Wobrock; J Zielasek Journal: Nervenarzt Date: 2013-03 Impact factor: 1.214
Authors: B Janssen; S Weinmann; M Berger; M Härter; T Held; M Leipert; H J Luderer; M Schwarz; T Steinert; W Gaebel Journal: Nervenarzt Date: 2005-03 Impact factor: 1.214
Authors: W Gaebel; T Becker; B Janssen; P Munk-Jorgensen; M Musalek; W Rössler; K Sommerlad; M Tansella; G Thornicroft; J Zielasek Journal: Eur Psychiatry Date: 2012-01-20 Impact factor: 5.361
Authors: I Großimlinghaus; I Hauth; P Falkai; B Janssen; A Deister; A Meyer-Lindenberg; C Roth-Sackenheim; F Schneider; T Wobrock; R Zeidler; W Gaebel Journal: Nervenarzt Date: 2017-07 Impact factor: 1.214
Authors: Daniela Fröhlich; Christin Bittersohl; Katrin Schroeder; Daniel Schöttle; Eva Kowalinski; Stefan Borgwardt; Undine E Lang; Christian G Huber Journal: Front Psychiatry Date: 2020-01-14 Impact factor: 4.157